Brian Tinmouth
Director/Board Member bei SCYNEXIS, INC.
Vermögen: 41 160 $ am 31.03.2024
Profil
Brian Philippe Tinmouth is currently an Independent Director at SCYNEXIS, Inc. since 2019 and the Chief Business & Strategy Officer at Mammoth Biosciences, Inc. since 2022.
Previously, he worked as the Vice President & Head-Business Development at Vertex Pharmaceuticals, Inc. from 2013 to 2020 and as a Senior Manager at Bain & Co., Inc. from 1997 to 2002.
He also served as the Chief Business & Strategy Officer at Pardes Biosciences, Inc. from 2021 to 2022.
Mr. Tinmouth completed his undergraduate degree at Queen's University and holds an MBA from Harvard Business School.
Bekannte Unternehmensbeteiligungen
Unternehmen | Datum | Anzahl der Aktien | Bewertung | Datum der Bewertung |
---|---|---|---|---|
SCYNEXIS, INC.
0,08% | 15.06.2023 | 28 000 ( 0,08% ) | 41 160 $ | 31.03.2024 |
Aktive Positionen von Brian Tinmouth
Unternehmen | Position | Beginn |
---|---|---|
SCYNEXIS, INC. | Director/Board Member | 13.12.2019 |
Mammoth Biosciences, Inc.
Mammoth Biosciences, Inc. Internet Software/ServicesTechnology Services Mammoth Biosciences, Inc. operates CRISPR-based platform for disease detection. The firm offers its services under the categories of bioinformatics, biotechnology, genetics, health diagnostics and life science. The company was founded by Ashley Tehranchi, Janice Chen, Jennifer A. Doudna, Lucas Harrington and Trevor Martin and is headquartered in South San Francisco, CA. | Corporate Officer/Principal | 01.12.2022 |
Ehemalige bekannte Positionen von Brian Tinmouth
Unternehmen | Position | Ende |
---|---|---|
PARDES BIOSCIENCES, INC. | Corporate Officer/Principal | 30.11.2022 |
VERTEX PHARMACEUTICALS INCORPORATED | Corporate Officer/Principal | 01.03.2020 |
Bain & Co., Inc.
Bain & Co., Inc. Miscellaneous Commercial ServicesCommercial Services Bain & Co., Inc. provides management consulting services. It offers advisory services to the companies on their critical issues and opportunities: strategy, marketing, organization, operations, technology and mergers and acquisitions, across all industries and geographies. The company was founded in 1973 and is headquartered in Boston, MA. | Corporate Officer/Principal | 01.01.2002 |
Ausbildung von Brian Tinmouth
Queen's University | Undergraduate Degree |
Harvard Business School | Masters Business Admin |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
Börsennotierte Unternehmen | 2 |
---|---|
VERTEX PHARMACEUTICALS INCORPORATED | Health Technology |
SCYNEXIS, INC. | Health Technology |
Private Unternehmen | 3 |
---|---|
Bain & Co., Inc.
Bain & Co., Inc. Miscellaneous Commercial ServicesCommercial Services Bain & Co., Inc. provides management consulting services. It offers advisory services to the companies on their critical issues and opportunities: strategy, marketing, organization, operations, technology and mergers and acquisitions, across all industries and geographies. The company was founded in 1973 and is headquartered in Boston, MA. | Commercial Services |
Mammoth Biosciences, Inc.
Mammoth Biosciences, Inc. Internet Software/ServicesTechnology Services Mammoth Biosciences, Inc. operates CRISPR-based platform for disease detection. The firm offers its services under the categories of bioinformatics, biotechnology, genetics, health diagnostics and life science. The company was founded by Ashley Tehranchi, Janice Chen, Jennifer A. Doudna, Lucas Harrington and Trevor Martin and is headquartered in South San Francisco, CA. | Technology Services |
Pardes Biosciences, Inc.
Pardes Biosciences, Inc. Pharmaceuticals: MajorHealth Technology Pardes Biosciences, Inc. is a clinical-stage biopharmaceutical company, which engages in discovering, developing and commercializing novel therapeutics to treat and prevent viral diseases. It also focuses on developing novel drugs to solve pandemic-sized problems like the coronavirus disease. The company was founded by Uri A. Lopatin and Lee D. Arnold on February 27, 2020 and is headquartered in Carlsbad, CA. | Health Technology |